Managing Immunogenicity Risk in Biopharmaceuticals 2012

Managing Immunogenicity Risk in Biopharmaceuticals 2012 is a webinar that covers topics such as:

• Risk factors associated with immunogenicity
• Self versus non-self
• How to use immunogenicity results from pre-clinical studies
• Regulatory expectations on immunogenicity testing
• Phase specific sampling plan
• Minimizing immunogenicity risk
• Case study and commercialization strategy

Managing Immunogenicity Risk in Biopharmaceuticals 2012 brings together Toxicologists, Pharmacologists, Project Managers, Clinicians, Consultants and Regulatory personnel from companies that are developing biopharmaceuticals that are NOT being used as vaccines.